Patient info

Cetirizine Hydrochloride 10 mg Film-coated Tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
No longer supplied
Medicine strength:
10 mg
Still supplied:
The same active substance, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Contains active substance:
ATC code:

Patient leaflet - Cetirizine Hydrochloride 10 mg tablets

1. WHAT CETIRIZINE IS AND WHAT IT IS USED FOR

Cetirizine dihydrochloride is the active ingredient of Cetirizine. Cetirizine is an antiallergic medication.

In adults and children aged 6 years and above, Cetirizine is indicated:

  • for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis.
  • for the relief of chronic nettle rash (chronic idiopathic urticaria).

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CETIRIZINE

Do not take Cetirizine:

  • if you have a severe kidney disease requiring dialysis;
  • if you are allergic to cetirizine dihydrochloride or any of the other ingredients of this medicine (listed in section 6), to hydroxyzine, to piperazine derivatives (closely related active substances of other medicines).

Warnings and precautions:

Talk to your doctor or pharmacist before taking Cetirizine Hydrochloride.

If you have problems passing urine (like spinal cord problems or prostate or bladder problems), please ask your doctor for advice.

If you are a patient with renal insufficiency, please ask your doctor for advice; if necessary, you will take a lower dose. The new dose will be determined by your doctor.

If you are an epileptic patient or a patient at risk of convulsions, you should ask your doctor for advice.

If you are going to perform an allergy test, ask your doctor if you should stop taking Cetirizine for several days before testing. This medicine may affect your allergy test results.

No clinically significant interactions have been observed between alcohol (at the blood level of 0.5 per mille (g/l) corresponding to one glass of wine) and cetirizine used at the recommended doses. However, there are no data available on the safety when higher doses of cetirizine and alcohol are taken together. Therefore, as it is the case with all antihistamines, it is recommended to avoid taking Cetirizine with alcohol.

Children

Do not give this medicine to children below the age of 6 years because the tablet formulation does not allow the necessary dose adjustments.

Other medicines and Cetirizine

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Cetirizine with food and drink

Food does not affect the absorption of cetirizine.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Cetirizine should be avoided in pregnant women. Accidental use of the medicine by a pregnant woman should not produce any harmful effects on the foetus. Nevertheless, the medicine should be only administered if necessary and after medical advice.

Cetirizine passes into breast milk. A risk of side effects in breastfed infants cannot be excluded. Therefore, you should not take Cetirizine during breast feeding unless you have contacted a doctor.

Driving and using machines

Clinical studies have produced no evidence of impaired attention, alertness and driving capabilities after taking Cetirizine at the recommended dose.

You should closely observe your response to the medicine after you have taken Cetirizine if you are intending to drive, engage in potentially hazardous activities or operate machinery. You should not exceed the recommended dose.

Cetirizine contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3. HOW TO TAKE CETIRIZINE

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Tablets need to be swallowed with a glass of liquid.

The tablet can be divided into equal doses.

Adults and adolescents above 12 years old

The recommended dose is 10 mg once daily as 1 tablet

Other form(s) of this medicine may be more suitable for children; ask your doctor or pharmacist.

Use in children between 6 and 12 years old

The recommended dose is 5 mg twice daily as a half tablet twice daily

Other form(s) of this medicine may be more suitable for children; ask your doctor or pharmacist.

Patients with renal impairment

Patients with moderate renal impairment are recommended to take 5 mg once daily.

If you suffer from severe kidney disease, please contact your doctor or pharmacist who may adjust the dose accordingly.

If your child suffers from kidney disease, please contact your doctor or pharmacist who may adjust the dose according to your child’s needs.

If you feel that the effect of Cetirizine is too weak or too strong, please consult your doctor.

Duration of treatment

The duration of treatment depends on the type, duration and course of your complaints and is determined by your doctor.

If you take more Cetirizine than you should

If you think you have taken an overdose of Cetirizine please inform your doctor.

Your doctor will then decide what measures, if any, should be taken.

After an overdose, the side effects described below may occur with increased intensity. Adverse effects such as confusion, diarrhoea, dizziness, tiredness, headache, malaise (feeling unwell), dilating of pupil, itching, restlessness, sedation, somnolence (sleepiness), stupor, abnormal rapid heart rate, tremors and urinary retention (difficulty in completely emptying the bladder) have been reported.

If you forget to take Cetirizine

Do not take a double dose to make up for a forgotten dose.

If you stop taking Cetirizine

Rarely, pruritus (intense itching) and/or urticaria (hives) may return if you stop taking Cetirizine.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects are rare or very rare, but you must stop taking Cetirizin Sandoz and seek for medical attention without delay if you experience symptoms like:

  • swelling in your mouth, face and/or throat
  • difficulties in breathing (chest tightness or wheezing)
  • sudden drop in your blood pressure with subsequent fainting or shock.

The symptoms can be signs of allergic reactions, anaphylactic shock and angioedema. These reactions may start soon after you first take the medicine, or it might start later.

The following outline contains further side effects listed by their frequency:

Common (may affect up to 1 in 10 people):

  • fatigue
  • dry mouth, nausea, diarrhoea
  • dizziness, headache
  • somnolence (sleepiness)
  • pharyngitis (sore throat), rhinitis (runny,stuffy nose) (in children)

Uncommon: (may affect up to 1 in 100 people):

  • agitation
  • abdominal pain
  • asthenia (extreme fatigue), malaise (feeling of being generally unwell)
  • paresthesia (abnormal feelings of the skin)
  • pruritus (itchy skin), rash

Rare: (may affect up to 1 in 1,000 people):

  • allergic reactions, some severe (very rare)
  • tachycardia (heart beating too fast)
  • oedema (swelling)
  • liver function abnormal
  • weight increased
  • convulsions
  • aggression, confusion, depression, hallucination, insomnia
  • urticaria (hives)

Very rare: (may affect up to 1 in 10,000 people):

  • thrombocytopenia (low blood platelets count manifested by bleeding or bruising more easily than normal)
  • accommodation disorder (difficulty focusing), blurred vision,

    oculogyric crisis (eyes having uncontrolled circular movements)

  • syncope (fainting), tremor, dysgeusia (altered taste), dyskinesia (involuntary movements), dystonia (abnormal prolonged muscular contractions)
  • tics (habit spasm)
  • abnormal elimination of urine (bed-wetting, pain and/or difficulty passing water)
  • angioedema (serious allergic reaction which causes swelling of the face or throat), fixed drug eruption (drug allergy)

Not known (Frequency cannot be estimated from the available data):

  • amnesia (memory loss), memory impairment
  • increased appetite
  • vertigo (sensation of rotation or movement)
  • urinary retention (inability to completely empty the urinary bladder)
  • nightmares
  • hepatitis (inflammation of the liver)
  • arthralgia (joint pain), myalgia (muscular pain)
  • acute generalized exanthematous pustulosis (rash with blisters containing pus)
  • pruritus (intense itching) and/or urticaria upon discontinuation
  • suicidal ideation (recurring thoughts of or preoccupation with suicide)

    If you feel this way, stop taking the tablets and see your doctor.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE CETIRIZINE

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the on the carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special temperature storage conditions.

Store in the original package in order to protect from light.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Cetirizine contains

Each tablet contains 10 mg of cetirizine dihydrochloride

  • The active substance is cetirizine dihydrochloride.
  • The other ingredients are

    Tablet core: cellulose microcrystalline, lactose monohydrate, magnesium stearate, silica, colloidal anhydrous

    Tablet coat: hypromellose, lactose monohydrate , titanium dioxide (E171) and macrogol 4000.

What Cetirizine looks like and contents of the pack

Cetirizine Hydrochloride 10 mg Tablets are white, oblong film-coated tablets, scored on one side.

PVC blister with aluminium foil lidding: 7, 10, 14, 20, 21, 28, 30, 50, 60, 98 and 100 and 50 (50x1) unit-dose.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Sandoz Limited

Maxis 1 Westen Road

Bracknell

United Kingdom

GU15 3YL

Manufacturer

Salutas Pharma GmbH

Otto-von-Guericke-Allee 1

39179 Barleben

Germany

This leaflet was last revised in 02/2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04416/0381

Last revision stated in the text: February 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Cetirizine Hydrochloride 10 mg tablets

Active substance Cetirizine
Strength 10 mg
Pharmaceutical form Oral tablet
White, oblong, scored on one side.
The tablet can be divided into equal doses.
How is it taken Oral
Excipients cellulose, microcrystalline, lactose monohydrate, magnesium stearate, silica, colloidal anhydrous, hypromellose, macrogol 4000, titanium dioxide (E 171)
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years.
Storage This medicinal product does not require any special temperature storage conditions. Store in original packaging to protect from light.
Drug group (ATC) Antihistamine for systemic use, Piperazine derivatives
  1. R Respiratory system drugs
    1. R06 Antihistamines for systemic use
      1. R06A Antihistamines for systemic use
        1. R06AE Piperazine derivatives, systemic antihistamines
          1. R06AE07 cetirizine
Marketing authorisation PL 04416/0381 (first authorised 28 April 2008)
Marketing authorisation holder Sandoz Limited
Codes BNF 03040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.